Clinical Trial Update: Continuation Treatment Protocol for Patients Who Participated in the Adagio TVP 1012/501 Clinical Trial

View source ↗

Summary

This document describes a continuation treatment protocol for patients who participated in the Adagio TVP 1012/501 Parkinson's trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• TVP-1012

Snippet

Sponsor: Rabin Medical Center | Conditions: Parkinson Disease | Status: UNKNOWN